Clinical Trials Browser

Unknown × Leiomyosarcoma × Doxorubicin × Clear all

Leiomyosarcoma

NCT02587169 2015-10-27

GEIS-27

Phase 1/2 Unknown

40 enrolled

Sarcoma

Retroperitoneal liposarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma

NCT00410462 2014-08-08

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Phase 2 Unknown

118 enrolled

GynecologicSarcoma

Malignant mesenchymal tumor, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Clinical Trials

FIBROSARC US

GEIS-27

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma